Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
 BACK TO LIST

European Patient Summary

Patient
Name: Markošová, Alan
DOB: 17-MAR-1941 (Age: 85)
Gender: male
ID: 3171-766886-2 (ECI)
Author
dr Jánošík, Edita
Patient summary Document
European Patient Summary
Report Date: 29-NOV-2024

Problem list

Condition Onset Date / Period Status
Metabolic syndrome X 01-Mar-2019 active
Alzheimer's disease 27-Oct-2018 active
Essential hypertension 12-Aug-2006 active
Substance dependence 25-Jun-2003 active
Ischemic heart disease 27-May-1995 active
Chronic intractable migraine without aura 06-Nov-1991 active
Impacted molars 28-Nov-1990 active
Anemia 16-Apr-1988 active
Acute bronchitis 31-Mar-2023 - 18-Apr-2023 inactive
Acute viral pharyngitis 27-Nov-2020 - 07-Dec-2020 inactive
Acute viral pharyngitis 22-Mar-2019 - 05-Apr-2019 inactive
Overdose 30-Oct-2018 - 30-Oct-2018 inactive
Concussion with loss of consciousness 16-Apr-2017 - 25-May-2017 inactive
Concussion injury of brain 16-Apr-2017 - 25-May-2017 inactive
Overdose 12-Mar-2017 - 13-Mar-2017 inactive
Overdose 21-Aug-2015 - 21-Aug-2015 inactive

Medication list

Medication Since Form Dosage Reason
Lisinopril 10 mg oral tablet 2024-11-29 - 1 tablet (10 mg) by mouth once daily Essential hypertension (disorder)
Albuterol sulfate 417 microgram/mL solution for inhalation 2024-11-29 - 2.5 mg (0.6 mL of 417 microgram/mL solution) via nebulizer every 4 to 6 hours as needed Childhood asthma
Acetaminophen 300 mg and hydrocodone bitartrate 5 mg oral tablet 2024-11-29 - 1 tablet (300 mg/5 mg) by mouth every 4 to 6 hours as needed for pain -
Fluticasone propionate 50 microgram/actuation nasal spray 2024-11-29 - 2 sprays (50 micrograms per spray) in each nostril once daily Childhood asthma
Donepezil (as donepezil hydrochloride) 5 mg and memantine (as memantine hydrochloride) 10 mg oral tablet 2022-03-23 - 1 tablet (5 mg/10 mg) once daily Alzheimer's disease (disorder)
Simvastatin 20 mg oral tablet 1995-06-02 - 1 tablet (20 mg) by mouth once daily -
Nitroglycerin 400 microgram/actuation sublingual spray 1995-06-02 - 400 micrograms (1 spray) under the tongue as needed for chest pain, may repeat every 5 minutes as needed, up to 3 sprays in 15 minutes -
Metoprolol tartrate (as metoprolol succinate) 100 mg prolonged-release oral tablet 1995-06-02 - 1 tablet (100 mg) once daily -
Vitamin B12 and/or vitamin B12 derivative-containing product 1988-04-22 - 1000 micrograms once daily -

Immunizations list

Vaccine Date
Influenza virus antigen only vaccine product 29-Nov-2024
SARS-CoV-2 mRNA vaccine 12-Feb-2021
Clostridium tetani toxoid antigen adsorbed only vaccine product 20-Oct-2017

Procedure History list

Procedure Date Reason
Depression screening 22-Apr-2023 -
Screening for domestic abuse 22-Apr-2023 -
Assessment of health and social care needs 21-Apr-2023 -
Assessment using Morse Fall Scale 21-Apr-2023 -
Medication reconciliation 14-Apr-2023 -
Assessment of anxiety 07-Apr-2023 -
Patient discharge 26-Aug-2021 -
Hospice care 25-Aug-2021 -
Notifications 20-Aug-2021 -
Certification procedure 20-Aug-2021 -
Initial patient assessment 20-Aug-2021 -
Development of individualized plan of care 20-Aug-2021 -
Depression screening using PHQ-9 (Patient Health Questionnaire 9) score 23-Feb-2019 -

Allergies and Intolerances

No known allergies or intolerances

Care Plan

Active Planned Care / Goals Start Date Reason
Dementia management 27-Oct-2018 Alzheimer's disease (disorder)
  • Patient will maintain orientation to person, place, and time as much as possible.
  • Patient will retain independence in basic activities of daily living such as bathing, dressing, and feeding.
  • Reduce frequency and severity of agitation, aggression, or other behavioral symptoms.
  • Patient or caregiver will administer dementia medications as prescribed.
  • Caregiver will receive education and support to manage patient’s dementia-related needs.
Lifestyle education regarding hypertension 12-Aug-2006 Essential hypertension (disorder)
  • Maintain blood pressure below 130/80 mmHg through lifestyle modifications.
  • Patient will adhere to recommended dietary, physical activity, and substance use modifications to support blood pressure control.
Care plan 30-Aug-2004 -
Diabetes self management plan 29-Mar-1985 Prediabetes (finding)
  • Patient will attend diabetes self-management education sessions to improve understanding of prediabetes and lifestyle modifications.
  • Maintain fasting plasma glucose within recommended range for prediabetes.
  • Maintain HbA1c below threshold for diabetes diagnosis.
  • Achieve and maintain weight loss as recommended for prediabetes management.
Asthma self management 27-Feb-1941 Childhood asthma (disorder)
  • Patient will demonstrate understanding of asthma self-management techniques, including inhaler use, trigger avoidance, and symptom monitoring.
  • Patient will report no more than two episodes of asthma symptoms per week.
  • Patient will take prescribed asthma medications as directed, with at least 90% adherence.
  • Patient will monitor and record peak expiratory flow rate daily.
Immunization Recommendation Due Date Reason
Influenza virus antigen only vaccine product 01-Oct-2026 Annual seasonal influenza vaccination

Vital Signs

Vital Signs 2024-11-29 2024-11-08
Body Height 171.6 cm -
Pain severity - 0-10 verbal numeric rating [Score] - Reported 1 {score} 5 {score}
Body Weight 83.4 kg -
Body mass index (BMI) [Ratio] 28.3 kg/m2 -
Heart rate 90 /min -
Respiratory rate 15 /min -
Blood pressure panel with all children optional 93 mm[Hg] -

Relevant diagnostic tests/laboratory data

Recent Lab Observations 29-NOV-2024 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 6.2 H 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 72.8 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 8.7 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.6 L 0.7 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 8.5 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 138.3 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.2 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 107.2 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 22.2 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 170.8 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 143.3 0 - 149 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 83.2 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 58.9 40 - 60 mg/dL

Device Use

Device Date (since)
Blood glucose meter (physical object) 29-Mar-1985